Avidity Partners Management LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1791827 DALLAS, TX

Position in VIR

as of Mar 31, 2026 · filed May 28, 2026 Compact

Position Value

$8,512,000

-$26,443,250 QoQ

Shares Held

950,000

-33.3% QoQ

Ownership

0.563%

of shares outstanding

% of Portfolio

1.69%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Avidity Partners Management LP holds $406,374,529 across 29 Biotechnology names. VIR ranks #8 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNTH	Dianthus Therapeutics, Inc. /DE/	2,104,184	$176,583,121
2	CGON	CG Oncology, Inc.	1,288,948	$87,236,000
3	ORKA	Oruka Therapeutics, Inc.	760,424	$37,298,797
4	JBIO	Jade Biosciences, Inc.	1,400,708	$19,679,947
5	ELVN	Enliven Therapeutics, Inc.	400,000	$15,680,000
6	CNTX	Context Therapeutics Inc.	4,998,267	$13,095,459
7	PVLA	Palvella Therapeutics, Inc.	70,000	$8,725,500
8	VIR	Vir Biotechnology, Inc. This page	950,000	$8,512,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,512,000	950,000	-33.3%	Shares	Sole	2026-05-28
2023-06-30	$34,955,250	1,425,000	-13.1%	Shares	Sole	2023-08-14
2023-03-31	$38,167,454	1,640,200	+93.0%	Shares	Sole	2023-05-15
2022-12-31	$21,513,500	850,000	+12.1%	Shares	Sole	2023-02-14
2022-06-30	$19,311,634	758,211	-2.8%	Shares	Sole	2022-08-15
2022-03-31	$20,061,600	780,000	+11.4%	Shares	Sole	2022-05-16
2021-12-31	$29,309,000	700,000	+35.9%	Shares	Sole	2022-02-14
2021-09-30	$22,412,800	515,000	+217.9%	Shares	Sole	2021-11-15
2021-06-30	$7,659,360	162,000	-73.9%	Shares	Sole	2021-08-16
2020-06-30	$25,425,982	620,600	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.